definitivahealthcarecorp-a 2025年季度报告

(Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the quarterly period endedSeptember 30,2025 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the transition period fromtoCommission File Number001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) Delaware(State or other jurisdiction ofincorporation or organization) 492 Old Connecticut Path, Suite 401Framingham,MA(Address of principal executive offices) 01701(Zip Code) (508)720-4224(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: DH Class A Common Stock, $0.001 par value The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was requiredto submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and“emerging growth company” in Rule 12b-2 of the Exchange Act. Large Accelerated Filer☐Non-accelerated Filer☐ Accelerated Filer☒Smaller reporting company☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).Yes☐No☒ As of November 3, 2025, the number of outstanding shares of the registrant’s Class A Common Stock was103,303,387shares. Definitive Healthcare Corp. Quarterly Report on Form 10-QFor the Quarterly Period Ended September 30, 2025 TABLE OF CONTENTS Glossary3Cautionary Note Regarding Forward-Looking Statements4Part I.FINANCIAL INFORMATION5Item 1.Condensed Consolidated Balance Sheets (Unaudited)5Condensed Consolidated Statements of Operations (Unaudited)6Condensed Consolidated Statements of Comprehensive Loss (Unaudited)7Condensed Consolidated Statements of Changes in Total Equity (Unaudited)8Condensed Consolidated Statements of Cash Flows (Unaudited)10Notes to the Condensed Consolidated Financial Statements (Unaudited)11Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations34Item 3.Quantitative and Qualitative Disclosures about Market Risk56Item 4.Controls and Procedures57Part II.OTHER INFORMATION58Item 1.Legal Proceedings58Item 1A.Risk Factors58Item 2.Unregistered Sales of Equity Securities and Use of Proceeds58Item 3.Defaults Upon Senior Securities59Item 4.Mine Safety Disclosures59Item 5.Other Information59Item 6.Exhibits60Signatures61 GLOSSARY As used in this Quarterly Report on Form 10-Q (“Quarterly Report”), the terms identified below have the meanings specifiedbelow unless otherwise noted or the context indicates otherwise. References in this Quarterly Report to “Definitive HealthcareCorp.” refer to Definitive Healthcare Corp. and not to any of its subsidiaries unless the context indicates otherwise. References inthis Quarterly Report to “Definitive Healthcare,” “Definitive,” the “Company,” “we,” “us,” and “our” refer to Definitive HealthcareCorp. and its consolidated subsidiaries unless the context indicates otherwise. •“Advent” refers to funds affiliated with Advent International, a global private equity firm.•“AIDH Buyer” refers to AIDH Buyer, LLC, which is a wholly owned subsidiary of Definitive OpCo (as the term isdefined below) and the direct parent company of DH Holdings.•“AIDH Management Holdings, LLC” is a special purpose investment vehicle through which certain persons, primarilyemployees and certain legacy investors, indirectly hold interests in Definitive OpCo.•“Amended LLC Agreement” refers to the second amended and restated limited liability company agreement enteredinto by Definitive Opco pursuant to which members have the right to exchange all or a portion of their LLC units (asthe term is defined below) for newly issued shares of Class A Common Stock in Definitive Healthcare Corp.•“ARR” refers to annual recurring revenue as of period end, which is calculated by aggregating annual subscriptionrevenue from committ